Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Li-Fraumeni Syndrome × Specimen Handling × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Lung Neoplasms 70 Prostatic Neoplasms 65 Leukemia, Myeloid, Acute 56 Neoplasm Metastasis 54 Carcinoma, Non-Small-Cell Lung 53 Breast Neoplasms 46 Colorectal Neoplasms 39 Multiple Myeloma 38 Pancreatic Neoplasms 35 Melanoma 31 Ovarian Neoplasms 29 Carcinoma, Renal Cell 29 Myelodysplastic Syndromes 28 Leukemia, Lymphocytic, Chronic, B-Cell 25 Triple Negative Breast Neoplasms 24 Urinary Bladder Neoplasms 22 Lymphoma, Large B-Cell, Diffuse 22 Glioblastoma 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Fallopian Tube Neoplasms 19 Squamous Cell Carcinoma of Head and Neck 18 Glioma 17 Brain Neoplasms 17 Endometrial Neoplasms 16 Carcinoma, Hepatocellular 16 Mouth Neoplasms 15 Burkitt Lymphoma 15 Lymphoma, Non-Hodgkin 14 Lymphoma, Follicular 14 Lymphoma 14

Interventions

Specimen Handling 1 Metformin 1 Mastectomy, Subcutaneous 1 Mastectomy 1 Diffusion Magnetic Resonance Imaging 1 Arsenic Trioxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04541654 2025-08-29

LiFT_UP

Dana-Farber Cancer Institute

Neoplastic Syndromes, Hereditary, Li-Fraumeni Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡